1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. VAXXINITY INC - ORDINARY SHARES - CLASS A

Vaxxinity Inc - Ordinary Shares - Class A

XNAS: VAXX

Watchlist

Portfolio

Share


Insider Trading disclosures for Vaxxinity Inc - Ordinary Shares - Class A

The latest disclosure was made by Gabrielle Toledano in Vaxxinity Inc - Ordinary Shares - Class A where a trade of 132,352 Stock option (right to buy) done was reported to US exchanges on June 20, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Gabrielle Toledano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2023 132,352 132,352 - - Stock option (right to buy)
George R. Hornig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2023 132,352 132,352 - - Stock option (right to buy)
Peter Powchik Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2023 132,352 132,352 - - Stock option (right to buy)
Peter H. Diamandis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2023 132,352 132,352 - - Stock option (right to buy)
Katherine A. Eade Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2023 132,352 132,352 - - Stock option (right to buy)
Landon Ogilvie Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2023 132,352 132,352 - - Stock option (right to buy)
James A. Smith Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2023 132,352 132,352 - - Stock option (right to buy)
Peter H. Diamandis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.57 per share. 26 Apr 2023 429,037 859,641 - 0.6 244,551 Class A common stock
Peter H. Diamandis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2023 46,500 732,642 - - Stock option (right to buy)
Peter H. Diamandis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Apr 2023 429,037 99,009 - - Stock option (right to buy)
Peter H. Diamandis Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.21 per share. 26 Apr 2023 46,500 906,141 - 1.2 56,265 Class A common stock
Jason Pesile See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2023 32,700 32,700 - - Stock Option (right to buy)
Mei Mei Hu Director, See Remarks, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2023 620,000 620,000 - - Stock Option (right to buy)
Ulo Palm See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2023 123,418 123,418 - - Stock Option (right to buy)
Rene Paula Molina See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2023 116,612 116,612 - - Stock Option (right to buy)
Louis Reese Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2023 301,188 301,188 - - Stock Option (right to buy)
Louis Reese Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2023 620,000 620,000 - - Stock Option (right to buy)
Louis Reese Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2023 61,607 61,607 - - Stock Option (right to buy)
Mei Mei Hu Director, See Remarks, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2023 73,928 73,928 - - Stock Option (right to buy)
George R. Hornig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 129,187 129,187 - - Stock option (right to buy)
Gregory R. Blatt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 129,187 129,187 - - Stock option (right to buy)
Peter Powchik Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 129,187 129,187 - - Stock option (right to buy)
Peter H. Diamandis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 129,187 129,187 - - Stock option (right to buy)
James Chui Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2022 129,187 129,187 - - Stock option (right to buy)
Mei Mei Hu Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.99 per share. 16 Jun 2022 100,000 51,737,344 - 2.0 199,290 Class A common stock
Louis Reese Director, Executive Chairman, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.99 per share. 16 Jun 2022 100,000 51,737,344 - 2.0 199,290 Class A common stock
Mei Mei Hu Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.72 per share. 08 Jun 2022 10,978 51,637,344 - 2.7 29,852 Class A common stock
Mei Mei Hu Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.95 per share. 08 Jun 2022 10,000 51,626,366 - 3.0 29,534 Class A common stock
Louis Reese Director, Executive Chairman, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.95 per share. 08 Jun 2022 10,000 51,626,366 - 3.0 29,534 Class A common stock
Louis Reese Director, Executive Chairman, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.72 per share. 08 Jun 2022 10,978 51,637,344 - 2.7 29,852 Class A common stock
Farshad Guirakhoo Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.57 per share. 03 May 2022 10,000 10,000 - 0.6 5,700 Class A common stock
Farshad Guirakhoo Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 May 2022 10,000 116,730 - - Stock Option (right to buy)
Louis Reese Director, Executive Chairman Purchase of securities on an exchange or from another person at price $ 3.45 per share. 26 Apr 2022 18,105 51,611,559 - 3.5 62,468 Class A common stock
Louis Reese Director, Executive Chairman Purchase of securities on an exchange or from another person at price $ 3.58 per share. 26 Apr 2022 4,807 51,616,366 - 3.6 17,222 Class A common stock
Mei Mei Hu Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.45 per share. 26 Apr 2022 18,105 51,611,559 - 3.5 62,468 Class A common stock
Mei Mei Hu Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.58 per share. 26 Apr 2022 4,807 51,616,366 - 3.6 17,222 Class A common stock
Louis Reese Director, Executive Chairman Purchase of securities on an exchange or from another person at price $ 3.37 per share. 25 Apr 2022 8,038 51,593,454 - 3.4 27,073 Class A common stock
Mei Mei Hu Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.37 per share. 25 Apr 2022 8,038 51,593,454 - 3.4 27,073 Class A common stock
Peter Powchik Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 94,186 94,186 - - Stock Option (right to buy)
Ulo Palm Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2022 100,000 100,000 - - Restricted Stock Units
Peter H. Diamandis Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.60 per share. 24 Jan 2022 312,659 430,604 - 8.6 2,688,867 Class A common stock
Farshad Guirakhoo (Former) Chief Scientific Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.57 per share. 13 Jan 2022 2,640 68,645 - 0.6 1,505 Class A common stock
Farshad Guirakhoo (Former) Chief Scientific Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.57 per share. 13 Jan 2022 26,005 66,005 - 0.6 14,823 Class A common stock
Farshad Guirakhoo (Former) Chief Scientific Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.57 per share. 13 Jan 2022 10,000 10,000 - 0.6 5,700 Class A common stock
Farshad Guirakhoo (Former) Chief Scientific Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.57 per share. 13 Jan 2022 20,000 40,000 - 0.6 11,400 Class A common stock
Farshad Guirakhoo (Former) Chief Scientific Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 26,005 60,725 - - Stock option (right to buy)
Farshad Guirakhoo (Former) Chief Scientific Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 20,000 86,730 - - Stock option (right to buy)
Farshad Guirakhoo (Former) Chief Scientific Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 2,640 58,085 - - Stock option (right to buy)
Farshad Guirakhoo (Former) Chief Scientific Off. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 10,000 116,730 - - Stock option (right to buy)
George R. Hornig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 67,953 67,953 - - Stock Option (right to buy)
Jason Pesile See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 51,225 51,225 - - Stock Option (right to buy)
James Chui Director Purchase of securities on an exchange or from another person at price $ 5.48 per share. 31 Dec 2021 6,000 14,000 - 5.5 32,880 Class A common stock
James Chui Director Purchase of securities on an exchange or from another person at price $ 7.89 per share. 10 Dec 2021 8,000 8,000 - 7.9 63,120 Class A common stock
Peter H. Diamandis Director Sale of securities on an exchange or to another person at price $ 13.00 per share. 18 Nov 2021 248 90,499 - 13 3,224 Class A common stock
Gregory R. Blatt Director Other type of transaction at price $ 0.00 per share. 16 Nov 2021 76,923 76,923 - 0 Class A common stock
Gregory R. Blatt Director Other type of transaction at price $ 0.00 per share. 16 Nov 2021 76,923 0 - 0 Class A common stock
Gregory R. Blatt Director 15 Nov 2021 622,516 622,516 - - Class A common stock
Ulo Palm Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2021 233,100 233,100 - - Stock option (right to buy)
Ulo Palm Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 13.00 per share. 15 Nov 2021 450 450 - 13 5,850 Class A common stock
Peter H. Diamandis Director 15 Nov 2021 21,511 0 - - Series A preferred stock
Peter H. Diamandis Director 15 Nov 2021 13,824 13,824 - - Class A common stock
Peter H. Diamandis Director 15 Nov 2021 13,824 13,824 - - Class A common stock
Gregory R. Blatt Director 15 Nov 2021 968,636 0 - - Series A preferred stock
Gregory R. Blatt Director 15 Nov 2021 83,329 0 - - Series A preferred stock
Gregory R. Blatt Director 15 Nov 2021 250,000 0 - - Series B preferred stock
Gregory R. Blatt Director 15 Nov 2021 160,668 160,668 - - Class A common stock
Gregory R. Blatt Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Nov 2021 76,923 76,923 - 0 Class A common stock
Gregory R. Blatt Director 15 Nov 2021 53,553 53,553 - - Class A common stock
Louis Reese Director, Executive Chairman 12 Nov 2021 6,554,643 0 - - Series A preferred stock
Mei Mei Hu Director, See Remarks, Ten Percent Owner 12 Nov 2021 422,696 0 - - Series A preferred stock
Mei Mei Hu Director, See Remarks, Ten Percent Owner 12 Nov 2021 247,050 51,585,416 - - Class A common stock
Mei Mei Hu Director, See Remarks, Ten Percent Owner 12 Nov 2021 6,554,643 0 - - Series A preferred stock
Mei Mei Hu Director, See Remarks, Ten Percent Owner 12 Nov 2021 384,410 0 - - Series A preferred stock
Louis Reese Director, Executive Chairman 12 Nov 2021 384,410 0 - - Series A preferred stock
Louis Reese Director, Executive Chairman 12 Nov 2021 422,696 0 - - Series A preferred stock
Louis Reese Director, Executive Chairman 12 Nov 2021 4,212,495 4,212,495 - - Class A common stock
Louis Reese Director, Executive Chairman 12 Nov 2021 247,050 51,585,416 - - Class A common stock
Louis Reese Director, Executive Chairman 12 Nov 2021 271,655 271,655 - - Class A common stock
Louis Reese Director, Executive Chairman Purchase of securities on an exchange or from another person at price $ 13.82 per share. 12 Nov 2021 17,500 17,500 - 13.8 241,920 Class A common stock
Mei Mei Hu Director, See Remarks, Ten Percent Owner 12 Nov 2021 271,655 271,655 - - Class A common stock
Mei Mei Hu Director, See Remarks, Ten Percent Owner 12 Nov 2021 4,212,495 4,212,495 - - Class A common stock
Mei Mei Hu Director, See Remarks, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 13.82 per share. 12 Nov 2021 17,500 17,500 - 13.8 241,920 Class A common stock
Farshad Guirakhoo Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2021 41,958 41,958 - - Stock option (right to buy)
Rene Paula Molina See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Nov 2021 96,153 96,153 - - Stock option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters